New eye scan may spot early damage in rare genetic disease
NCT ID NCT07006649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special eye scan can detect early blood flow changes in the retina of people with pseudoxanthoma elasticum (PXE), a rare genetic disease that can cause vision loss. Researchers will compare 30 PXE patients with 30 healthy volunteers matched by age and gender. The goal is to find a reliable marker to track the disease, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify a way to track PXE eye damage earlier, helping future studies measure disease progression.
- What could go wrong
- This is an early observational study with only 60 people. It does not test any treatment, so it cannot directly improve vision or slow the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOXANTHOMA ELASTICUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Angers University Hospital
RECRUITINGAngers, 49000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do common prostate drugs change the eye? a trial investigates
- Can a common prostate drug spare the eye during cataract surgery?
- Could a smartphone camera spot blinding eye diseases?
- Could stem cells restore sight in damaged eyes?
- New eye scanner aims to sharpen view of retinal disease
- New eye camera could spot retinal disease earlier